LVW Advisors
BIIB icon

LVW Advisors’s Biogen BIIB Stock Holding History

LVW Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$305K Buy
1,351
+197
+17% +$41.8K 0.03% 365
2026
Q2 		$249K Sell
1,154
-535
-32% -$102K 0.02% 389
2026
Q1 		$310K Buy
+1,689
New +$311K 0.03% 320

Other funds holding BIIB

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

LVW Advisors's BIIB Position: Q3 2026 in Review

LVW Advisors increased its Biogen (BIIB) stake by 17% in Q3 2026, buying an estimated $41.8K and bringing the position to 1,351 shares worth $305K. The position accounts for 0.03% of the portfolio, ranked #365.

LVW Advisors first reported a position in BIIB in Q1 2026 and has held it in 3 quarters since. The position peaked at $310K in Q1 2026. 532 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • LVW Advisors held 1,351 shares of Biogen worth $305K as of Q3 2026.
  • LVW Advisors bought 197 Biogen shares in Q3 2026, an estimated $41.8K.
  • Biogen made up 0.03% of LVW Advisors's portfolio in Q3 2026, its #365 holding.
  • LVW Advisors first reported a position in Biogen in Q1 2026 and has held it in 3 quarters since.
  • LVW Advisors's Biogen position peaked at $310K in Q1 2026.
  • 532 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on LVW Advisors's 13F filing for Q3 2026, filed 19 Oct 2026.